Original Research
Accepted on 25 Nov 2025
Characterization of Ocular Adverse Events Associated with Crizotinib: Real-World Insights from the Two Global Pharmacovigilance Databases of FAERS and VigiBase
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 25 Nov 2025
in Cancer Molecular Targets and Therapeutics
Editorial
Accepted on 25 Nov 2025
in Machine Learning and Artificial Intelligence
Review
Accepted on 25 Nov 2025
in Cardiovascular Epidemiology and Prevention
Mini Review
Accepted on 25 Nov 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 25 Nov 2025
in Technology and Law
Original Research
Accepted on 25 Nov 2025
in Medicine and Public Health
Editorial
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Nov 2025
in Physical Oceanography
Study Protocol
Accepted on 25 Nov 2025
in Endovascular and Interventional Neurology
Original Research
Accepted on 25 Nov 2025
in Social Psychiatry and Psychiatric Rehabilitation
Original Research
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Nov 2025
in Biomaterials
Case Report
Accepted on 25 Nov 2025
in Cancer Immunity and Immunotherapy